2021年

Fukui-Kawaura S, Kawahara T, Araki Y, Nishimura R, Uemura K, Namura K, Mizuno N, Yao M, Uemura H, Ikeda I: A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer. Oncotarget,12(9):917-922,2021.

Fujita Y, Suzuki A, Asaoka M, Jikuya R, Mitome T, Ohtake S, Tatenuma T, Yamanaka H, Ito Y, Muraoka K, Makiyama K, Kondo K, Nakaigawa N, Enaka M, Yao M:A Case of Lymphoepithelioma-Like Carcinoma of the Ureter. Hinyokika Kiyo,67:205-209,2021. 

Ishida H, Nakamura M, Komaba H, Uehara S, Takiguchi S , Fukagawa M: Post-kidney transplant soluble Klotho levels are determined by pretransplant soluble Klotho levels in both living donors and recipients. Observational Study Clin Exp Nephrol, 25(12):1367-1374,2021.

Ito H, Sales AC, Fry CH, Kanai AJ, Drake MJ, Pickering AE:Probabilistic, spinally-gated control of bladder pressure and autonomous micturition by Barrington’s nucleus CRH neurons.Elife,2020 Apr 29;9. pii: e56605. doi: 10.7554/eLife.56605. [Epub ahead of print]
 

Iribe Y, Furuya M, Shibata Y, Yasui M, Funahashi M, Ota J, Iwashita H, Nagashima Y, Hasumi H, Hayashi N, Makiyama K, Kondo K, Tanaka R, Yao M, Nakaigawa N. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. Fam Cancer, 20(1):75-80,2021.

Iwamoto G, Kawahara T, Yokomizo Y, Miyoshi Y, Yao M, Uemura H：The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer. Asian J Urol, 8(3):332-334,2021. 

Iwamoto G, Kawahara T, Miyai T, Yasui M, Hasumi H, Miyoshi Y, Yao M, Uemura H:A lower psoas muscle index predicts a poorer prognosis in metastatic hormone‐naïve prostate cancer. BJUI Compass,2(1):39-45,2021.

Kawahara T, Ninomiya S, Tsutsumi S, Ito H, Yao M, Uemura H: Impact of depression on overactive bladder. Int J Urol,28(2):245-246,2021.
 

Kishida T :Editorial Comment to Predictors of postoperative recurrence in patients with non-metastatic pT3a renal cell carcinoma.Int J Urol, 28:1067,2021.
 

Komeya M, Odaka H, Watanabe T, Kiuchi H, Ogawa T, Yao M, Matsuzaki J:Gap between UAS and ureteroscope predicts renal stone-free rate after flexibleureteroscopy with the fragmentation technique.World J Urol, 39(7):2733-2739,2021.

Makiyama K, Osaka K, Araki A, Ohtake S, Tatenuma T, Nagasaka M, Yamada T, Yao M：How to reduce the risk of organ injuries during surgical instrument insertion in laparoscopic surgery: Pushing/pressing force analysis using forceps with sensors. Asian J Endosc Surg,14(3):504-510,2021.

Makiyama K, Tatenuma T, Ohtake S, Suzuki A, Muraoka K, Yao M. Clinical use of a patient-specific simulator for patients who were scheduled for robot-assisted laparoscopic partial nephrectomy. Int J Urol. 28:130-132,2021.

Makiyama K:Editorial Comment to Robot-assisted partial nephrectomy versus standard laparoscopic partial nephrectomy for renal hilar tumor:A prospective multi-institutional study. Int J Urol. 28:389,2021.

Miyoshi Y, Yasui M, Ttsutsumi S, Kawahara T, Uemura K, Hayashi N, Nozawa M, Yoshimura K, Uemura H, Uemura H ：Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients. BJUI Compass,2(1):31-38,2021.

Miyoshi Y, Yasui M, Yoneyama S, Kawahara T,Nakagami Y, Ohno Y, Iizuka J, Tanabe K, Hashimoto Y：A novel prognostic model for 
Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer.BJUI Compass, 2(2)105-114,2021.

Miyoshi Y, Tsutsumi S, Kawahara T, Yasui M, Uemura K, Yoneyama s, Yokomizo Y, Hayashi N, Yao M, Uemura H:Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐23.BJUI Compass, 2(1):24-30,2021.

Miyoshi Y, Tsutsumi S, Yasui M, Kawahara T, Uemura K, Hayashi N, Nozawa M, Yoshimura K, Uemura H, Uemura H: A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer. World J Urol,39(9):3323-3328,2021.

Nirei T, Tabei T, Ito H, Kobayashi K: A case of renal pelvic cancer with a complete duplication of the renal pelvis and ureter．Case reports in Oncology,14(1):202-206,2021.

Nirei T, Tabei T, Ito H, Kobayashi K:Effect of intra-institutional standardization of using intraoperative fluoroscopy in ureteroscopy. 横浜医学,72(4):489-494,2021.

Nirei T, Nakaigawa N, Matsubara M, Kataoka T, Nagasaka T, Aomori K, Ito Y, Muraoka K, Yao M.: Case of inverted papillary urothelial carcinoma in the ureter. IJU Case reports.5(2):95-98,2021.　

Shibata Y, Noguchi G, Suzuki T, Osaka K, Umemoto S, Kishida T:Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma 
After Immune-Related Interstitial Pneumonia.A Case Report.Am J Case Rep,22:e932924,2021.

 

Tabei T, Horiguchi A, Ojima K, Shinchi M, Kobayashi K, Ito K and Azuma R: Efficacy of re-do urethroplasty for post-traumatic urethral stricture: An analysis of the anatomical and functional outcomes. Int J Urol, 28:742-747,2021.

Tatenuma T, Makiyama K, Ito Y, Muraoka K, Hasumi H, Hayashi N, Kondo K, Nakaigawa N, Yao M:Correlation of urinary loss rate after catheter removal and long-term urinary continence after robot-assisted laparoscopic radical prostatectomy. Int J Urol,28:440-443,2021.

Uemura H, Arai G, Uemura H, Suzuki H, Iijima K, Nishimura K, Fujii K, Hatayama T, Aoyama J, Deprince K, Lopez-Gitlitz A, McCarthy S, Larsen JS, Li J, Chi KN:Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.Int J Urol,28(3):280-287, 2021.

Uemura H, Matsushima H, Yokomizo A, Kobayashi K, Arai G, Satoh T, Grillo V, Chen Y, Singh S, Ledesma DA:Unmet needs in non-metastatic castration-resistant prostate cancer from the Japanese patient perspective: a discrete choice experiment. BMJ Open, 11(8):e052471, 2021.

Uemura H, Matsushima H, Kobayashi K, Mizusawa H, Nishimatsu H, Fizazi K, Smith M, Shore N, Tammela T, Tabata KI, Matsubara N, Iinuma M, Uemura H, Oya M, Momma T, Kawakita M, Fukasawa S, Kobayashi T, Kuss I, Le Berre MA, Snapir A, Sarapohja T, Suzuki K: Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial. Int J Clin Oncol, 26(3):578-590. 2021.

​

小泉充之,中島健寛,西村玲応奈,深澤佳高,藤川　敦：前立腺肥大症に対するツリウムレーザーを用いた蒸散術および核出術の検討．泌尿器外科,34(1)：71-76, 2021.
 

小林幸太,米山脩子,藤川直也,滝沢明利:悪性腫瘍による尿管狭窄に対するステンレスメッシュ入り尿管ステントの使用経験.Japanese Journal of Endourology,34:154-158, 2021.
 

小林幸太,川畑さゆき,苅部樹里衣,米山脩子,藤川直也,滝沢明利:ペムブロリズマブ投与後に続発性副腎機能低下症をきたした尿管癌の1例.泌尿器外科,34:419-423,2021.
 

齋藤智樹, 田尻下紘直, 菅野ひとみ, 蒋 世旭, 森永亮太, 星野耕二：血性帯下を主訴に受診した高齢の会陰悪性黒色腫の1例.泌尿器外科,34(1):101-104,2021.
 

齋藤智樹, 田尻下紘直, 佐々木 了, 菅野ひとみ：頸椎への骨転移を契機に発見された血清PSA高値の原発不明癌の1例.泌尿器外科,34(3):297-301,2021.
 

蓼沼知之，槙山和秀：【泌尿器科当直医マニュアル】入院編　術後合併症　仮性動脈瘤(腎部分切除術・腎外傷・腎生検・経皮的腎瘻造設術後の肉眼的血尿)．
 

臨床泌尿器科,75：214-216,2021.
 

田部井正：当院におけるECIRSの実際～合併症を減らすためにしていること～. 泌尿器外科,34:718-721,2021．

 

福田哲央,近藤拓也,新堀萌香,平澤輝一,佐野　太,村上貴之：両側副腎原発びまん性大細胞型Ｂ細胞リンパ腫の1例. 泌尿器外科, 34(1):84-87,2021.
 

山崎将頌, 槙山和秀,川畑　遼,他：cT1a vs cT1b腎腫瘍に対する当院におけるロボット支援腎部分切除術の比較検討. Jap J Endourol,34：300-306,2021.